Top Markets
Coin of the day
RayzeBio, Inc. Common Stock RayzeBio, Inc. Common Stock

RayzeBio, Inc. Common Stock

RYZB
Rankning i aktier #5675
RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs)... RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs) for oncology applications. Its primary therapeutic candidate, RYZ101, is currently advancing through Phase 3 clinical trials for the management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The company's innovative pipeline also features RYZ801, a distinct peptide engineered to deliver Actinium-225 (Ac225) by targeting GPC3, intended for treating hepatocellular carcinoma (HCC). Additionally, RayzeBio is developing RYZ811, a companion diagnostic imaging agent comprising a peptide binder, a chelator, and Gallium-68 (Ga68). Another active development program involves a novel proprietary small molecule designed to target CA9, delivering Ac225 for potential use against clear cell renal cell carcinoma (ccRCC). The firm was established in 2020 and is headquartered in San Diego, California.
Aktiekurs
$62.49
Senast synkroniserad: 2024-03-06
Marknadsvärde
$2.52B
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel RayzeBio, Inc. Common Stock (RYZB)

Kategori

Historik för aktiesplit för RayzeBio, Inc. Common Stock (RYZB)
Aktien RayzeBio, Inc. Common Stock (symbol: RYZB) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 27, 2026.
En RYZB-aktie köpt före Aug 27, 2026 motsvarar nu 0 RYZB-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH